Publication | Open Access

Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine—a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays

Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryMedicinePreclinical AssaysPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentAnti-tumor ActivityPharmacologyRadiation OncologyCancer ResearchTumor BiologyDrug DiscoveryPre-clinical Pharmacology